Healthcare
Sensus Healthcare, Inc.(SRTS)
Live Price
Offline$2.71
+0.00% today
1Y Change
-41.01%
Window
Jun 20, 2025 โ Jun 18, 2026
- Market Cap
- $70.00M
- Revenue Growth
- -34.3%
- EPS Growth
- -214.6%
- Dividend Yield
- 0.0%
Coverage: 250 bars ยท Jun 20, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sensus Healthcare, Inc. (SRTS) is a Healthcare stock with a market cap of $70.00M and listed on NASDAQ. The stock last traded around $2.71 and down 41.0% across the available one-year price window (Jun 20, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of -34.3%, EPS growth of -214.6%, a dividend yield of 0.0%. What stands out right now is revenue -34.3%, EPS -214.6%, free cash flow +130.0% with operating margin -37.5% and ROIC -17.0%. Valuation is more restrained than many high-expectation growth names at price/sales 2.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SRTS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-34.3% vs +7.6% peer median
Operating Margin
Below sector median
-37.5% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -34.3% and EPS is at -214.6%, with operating margin around -37.5%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.4% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | +0.0% | -10.5% | -24.9% |
2026 Feb 12, 2026 | -245.4% | -17.0% | -15.1% | -16.3% |
2025 Nov 6, 2025 | +45.5% | +19.3% | +26.7% | +10.8% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SRTS
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SRTS Max Drawdown
-52.39%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SRTS and SPY.
Company Overview
Sensus Healthcare, Inc.
NASDAQ Capital Market
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
- Leadership
- Joseph C. Sardano
- IPO Date
- Jul 26, 2016
- Employees
- 54
- Street Address
- 851 Broken Sound Parkway NW
- Mailing
- Boca Raton, FL, 33487
- Region
- Boca Raton, FL, US
- Reporting Currency
- USD
- Investor Line
- 561 922 5808
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 2.4
- Price/Book
- 1.4
Growth
- Revenue
- -34.3%
- EPS
- -214.6%
- Free Cash Flow
- +130.0%
Profitability
- Gross Margin
- 43.2%
- Operating Margin
- -37.5%
- Net Margin
- -28.1%
- ROE
- -15.1%
- ROIC
- -17.0%
Balance Sheet
- Debt/Equity
- 0.01
- Current Ratio
- 9.72
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.